Cargando…

Th1 cytokines in pediatric acute lymphoblastic leukemia

Immune milieus play an important role in various types of cancer. The present study focuses on the effect of Th1 cytokines on pediatric acute lymphoblastic leukemia (ALL). The reaction of ALL cell lines and patient-derived xenografts (PDX) to the most important Th1 cytokines TNF-α (tumor necrosis fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schober, Sarah, Rottenberger, Jennifer M., Hilz, Johannes, Schmid, Evi, Ebinger, Martin, Feuchtinger, Tobias, Handgretinger, Rupert, Lang, Peter, Queudeville, Manon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576712/ https://www.ncbi.nlm.nih.gov/pubmed/37610672 http://dx.doi.org/10.1007/s00262-023-03512-5

Ejemplares similares

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab
por: Queudeville, Manon, et al.
Publicado: (2017)

Blinatumomab in Pediatric Acute Lymphoblastic Leukemia—From Salvage to First Line Therapy (A Systematic Review)
por: Queudeville, Manon, et al.
Publicado: (2021)

T-cell responses against CD19(+) pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts
por: Feucht, Judith, et al.
Publicado: (2016)

Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
por: Trentin, Luca, et al.
Publicado: (2014)

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
por: Demir, Salih, et al.
Publicado: (2020)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2019)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT(3)-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Cabanillas Stanchi, Karin Melanie, et al.
Publicado: (2020)

Editorial to: Advance in the Treatment of Pediatric Leukemia
por: Handgretinger, Rupert
Publicado: (2022)

Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma—a pilot study
por: Stagno, Matias J., et al.
Publicado: (2022)

Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
por: Döring, Michaela, et al.
Publicado: (2012)

An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia
por: Riegg, Fabian, et al.
Publicado: (2021)

Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
por: Gore, Lia, et al.
Publicado: (2018)

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
por: Locatelli, Franco, et al.
Publicado: (2020)

Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma
por: Urla, Cristian, et al.
Publicado: (2022)

D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma
por: Urla, Cristian, et al.
Publicado: (2022)

Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
por: Locatelli, Franco, et al.
Publicado: (2021)

Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia
por: Pfeiffer, Matthias Manuel, et al.
Publicado: (2013)

Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
por: Locatelli, Franco, et al.
Publicado: (2021)

Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
por: Locatelli, Franco, et al.
Publicado: (2022)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model
por: Hasan, Md. Nabiul, et al.
Publicado: (2014)

Treatment of graft failure with TNI‐based reconditioning and haploidentical stem cells in paediatric patients
por: Teltschik, Heiko‐Manuel, et al.
Publicado: (2016)

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
por: Flaadt, Tim, et al.
Publicado: (2023)

Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia
por: Krętowska-Grunwald, Anna, et al.
Publicado: (2023)

LGG-51. Resection extent and BRAF V600E mutation status determine postoperative growth velocity in pediatric Low-grade glioma: Results from a single-center cohort analysis
por: Gorodezki, David, et al.
Publicado: (2022)

mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo
por: Zeyer, Franziska, et al.
Publicado: (2016)

Correction: mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo
por: Zeyer, Franziska, et al.
Publicado: (2018)

Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia
por: Schirmer, M, et al.
Publicado: (2016)

Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.
por: Escherich, Gabriele, et al.
Publicado: (2021)

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation
por: Döring, Michaela, et al.
Publicado: (2015)

Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
por: Burke, Michael J., et al.
Publicado: (2014)

Bone morbidity in pediatric acute lymphoblastic leukemia
por: Ahn, Moon Bae, et al.
Publicado: (2020)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature
por: Schober, Sarah, et al.
Publicado: (2020)

Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis
por: Gorodezki, David, et al.
Publicado: (2022)

Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia
por: Tiziani, Stefano, et al.
Publicado: (2013)

Recent advances in the management of pediatric acute lymphoblastic leukemia
por: Starý, Jan, et al.
Publicado: (2016)

Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia
por: Chennamaneni, Rachana, et al.
Publicado: (2018)

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_npt6florn7ri6070ld3pd11oqn